1212 · 28/04/2026 08:00:23 · Announcement #94714 · View on Saudi Exchange

Astra Industrial Group announces its Interim Financial results for the Period Ending on 2026-03-31 ( Three Months )

Element ListCurrent QuarterSimilar quarter for previous year%ChangePrevious Quarter% Change
Sales/Revenue 790,909,047833,728,170-5.135791,827,797-0.116
Gross Profit (Loss) 385,259,335372,598,0033.398368,859,7314.446
Operational Profit (Loss) 192,085,715189,301,1151.47119,688,56960.487
Net Profit (Loss) Attributable to Shareholders of the Issuer 173,138,809171,871,0960.737152,574,25213.478
Total Comprehensive Income Attributable to Shareholders of the Issuer 172,515,689176,723,126-2.38156,953,9699.914
All figures are in (Actual) Saudi Arabia, Riyals
Element ListCurrent PeriodSimilar period for previous year%Change
Total Shareholders Equity (after Deducting Minority Equity) 3,134,506,3712,700,529,20416.07
Profit (Loss) per Share 2.162.15
All figures are in (Actual) Saudi Arabia, Riyals
Element ListAmountPercentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value --
All figures are in (Actual) Saudi Arabia, Riyals
Element ListExplanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is Revenue decreases in general due to:

Decrease in revenue in the following segments:

a) Steel Industry

b) Specialty chemical.

While noting that there is slight increase in revenue in pharmaceuticals segment.The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is Net profit Increases in general due to:

1. Increase in Gross Profit in the following segments:

a) Pharmaceuticals

b) Steel Industry

2. Decrease in finance costs mainly in the following segments:

a) Specialty Chemical

b) Pharmaceuticals.

While noting that there is decrease in other income, net in other segment.The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is Sales decrease in general due to:

Decrease in sales in steel segment.

While noting that there is increase in sales in the pharmaceuticals segment.The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is Net profit Increases in general due to:

1. Increase Gross Profit in Profit in the following segments:

a. Pharmaceuticals

b. Specialty chemical

While noting that there is decrease in Gross Profit in Steel industries.

2. Decrease in General and administrative expenses in following sectors:

a) Steel industries

b) Specialty chemical

3. Decrease in Provision for impairment of financial assets expenses in following sectors:

a) Steel industries

b) Specialty chemical

While noting that there is decrease in share in profit from unconsolidated subsidiary.Statement of the type of external auditor's report Unmodified conclusionComment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) N\AReclassification of Comparison Items Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period.Additional Information Net Shareholders’ Equity at the end of the period was SR 3,133,945,566/- compared to SR 2,707,857,633 /- at the end of the similar period last year with an increase of 16%.

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.